Multivariate analyses for overall survival of patients with MSS

FactorPExp (B)95% CI min95% CI max
Primary tumor
(yes vs. no)
0.0500.330.101.00
Ascites
(yes vs. no)
< 0.0010.200.080.49
Line of immunotherapy (I–II vs. III–IV)0.0040.240.090.63
NLR
(< 1.8 vs. ≥ 1.8)
0.0060.230.080.65

MSS: microsatellite stable; NLR: neutrophil-lymphocyte ratio